80 related articles for article (PubMed ID: 20527231)
21. Prospective evaluation of the molecular effects of metformin on the endometrium in women with newly diagnosed endometrial cancer: A window of opportunity study.
Soliman PT; Zhang Q; Broaddus RR; Westin SN; Iglesias D; Munsell MF; Schmandt R; Yates M; Ramondetta L; Lu KH
Gynecol Oncol; 2016 Dec; 143(3):466-471. PubMed ID: 27745917
[TBL] [Abstract][Full Text] [Related]
22. Is there any difference between endometrial hyperplasia and endometrial carcinoma in terms of expression of TRPM2 and TRPM7 ion channels?
Yalçın E; Pala Ş; Atılgan R; Kuloğlu T; Önalan E; Artaş G; Buran İ
Turk J Med Sci; 2019 Apr; 49(2):653-660. PubMed ID: 30997980
[TBL] [Abstract][Full Text] [Related]
23. Risk-stratification machine learning model using demographic factors, gynaecological symptoms and β-catenin for endometrial hyperplasia and carcinoma: a cross-sectional study.
Masadah R; Maulana A; Nelwan BJ; Ghaznawie M; Miskad UA; Tawali S; Rauf S; Herman B
BMC Womens Health; 2023 Nov; 23(1):627. PubMed ID: 38008739
[TBL] [Abstract][Full Text] [Related]
24. Expression and clinical significance of HER2/neu, aromatase P450 and adhesion molecule CD24 in endometrial cancer.
Guan L; Wang Y; Cheng J; Zhang J; Kang S
Eur J Histochem; 2023 Aug; 67(3):. PubMed ID: 37565251
[TBL] [Abstract][Full Text] [Related]
25. Canonical and noncanonical Wnt pathways: a comparison between endometrial cancer type I and atrophic endometrium in Brazil.
Menezes Mde P; Oshima CT; Filho LB; Gomes TS; Barrezueta LF; Stávale JN; Gonçalves WJ
Sao Paulo Med J; 2011; 129(5):320-4. PubMed ID: 22069131
[TBL] [Abstract][Full Text] [Related]
26. DNA methylation of selected tumor suppressor genes in endometrial hyperplasia.
Dvorak O; Ndukwe M; Slavickova M; Laco J; Spacek J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2024 Mar; 168(1):68-73. PubMed ID: 36628559
[TBL] [Abstract][Full Text] [Related]
27. Improving the Diagnosis of Endometrial Hyperplasia Using Computerized Analysis and Immunohistochemical Biomarkers.
Sanderson PA; Esnal-Zufiaurre A; Arends MJ; Herrington CS; Collins F; Williams ARW; Saunders PTK
Front Reprod Health; 2022; 4():896170. PubMed ID: 36303676
[TBL] [Abstract][Full Text] [Related]
28. Association of body mass index with early age at diagnosis of endometrial intraepithelial neoplasia.
Nicholson K; Macharia A; Furuya R; Manning C; Hacker MR; Harris DA; Esselen K; Dottino J
Gynecol Oncol; 2023 Aug; 175():15-19. PubMed ID: 37290247
[TBL] [Abstract][Full Text] [Related]
29. Divergent Malignant Melanocytic Differentiation in Ovarian Endometrioid Adenocarcinoma With Aberrant β-Catenin Expression: A Case Expanding the Histologic Spectrum of β-Catenin Activated Gynecologic Neoplasia.
Xu J; Weisman PS
Int J Gynecol Pathol; 2024 May; 43(3):302-307. PubMed ID: 37922945
[TBL] [Abstract][Full Text] [Related]
30. Machine learning for prediction of concurrent endometrial carcinoma in patients diagnosed with endometrial intraepithelial neoplasia.
Levin G; Matanes E; Brezinov Y; Ferenczy A; Pelmus M; Brodeur MN; Salvador S; Lau S; Gotlieb WH
Eur J Surg Oncol; 2024 Mar; 50(3):108006. PubMed ID: 38342041
[TBL] [Abstract][Full Text] [Related]
31. Incidence of endometrial carcinoma in patients with endometrial intraepithelial neoplasia versus atypical endometrial polyp.
Cohen A; Tsur Y; Tako E; Levin I; Gil Y; Michaan N; Grisaru D; Laskov I
Int J Gynecol Cancer; 2022 Dec; ():. PubMed ID: 36600505
[TBL] [Abstract][Full Text] [Related]
32. The first evidence of mismatch repair deficiency in mesonephric-like adenocarcinoma of the endometrium: clinicopathological and molecular features of a case emphasising a possible endometrioid carcinogenesis.
Angelico G; Salvatorelli L; Tinnirello G; Santoro A; Zannoni GF; Puzzo L; Magro G
Histopathology; 2024 May; 84(6):1068-1070. PubMed ID: 38173293
[No Abstract] [Full Text] [Related]
33. Predicting Progestin Therapy Response With PTEN, PAX2, and β-Catenin in Patients With Endometrioid Precancer.
Liu N; Lin W; Wang Y; Yao Z; Rivera-Colon G; Li Y; Carrick KS; Chen H; Lucas E; Zheng W
Int J Gynecol Pathol; 2024 Jan; ():. PubMed ID: 38293998
[TBL] [Abstract][Full Text] [Related]
34. Oreste Ghisalba - ein Nachruf.
Gygax D
Chimia (Aarau); 2019 Feb; 73(1-2):99-100. PubMed ID: 30814013
[No Abstract] [Full Text] [Related]
35. Nuclear expression of β-catenin in endometrial hyperplasia as marker of premalignancy.
Travaglino A; Raffone A; Saccone G; Mascolo M; D'Alessandro P; Arduino B; Mollo A; Insabato L; Zullo F
APMIS; 2019 Nov; 127(11):699-709. PubMed ID: 31403731
[TBL] [Abstract][Full Text] [Related]
36. Biomarkers in the Diagnosis of Endometrial Precancers. Molecular Characteristics, Candidate Immunohistochemical Markers, and Promising Results of Three-Marker Panel: Current Status and Future Directions.
Niu S; Molberg K; Castrillon DH; Lucas E; Chen H
Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539494
[TBL] [Abstract][Full Text] [Related]
37. Relationships between expression of glucose transporter protein-1 and hypoxia inducible factor-1α, prognosis and
Shen LF; Zhou SH; Yu Q
Transl Cancer Res; 2020 Apr; 9(4):2824-2837. PubMed ID: 35117639
[TBL] [Abstract][Full Text] [Related]
38. New concepts for an old problem: the diagnosis of endometrial hyperplasia.
Sanderson PA; Critchley HO; Williams AR; Arends MJ; Saunders PT
Hum Reprod Update; 2017 Mar; 23(2):232-254. PubMed ID: 27920066
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
